Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where R. Hofmann-Wellenhof is active.

Publication


Featured researches published by R. Hofmann-Wellenhof.


British Journal of Dermatology | 2004

Clinically equivocal melanocytic skin lesions with features of regression: a dermoscopic-pathological study.

Iris Zalaudek; Giuseppe Argenziano; G. Ferrara; Hp Soyer; Rosamaria Corona; Francesco Sera; Lorenzo Cerroni; Andreina Carbone; A. Chiominto; Lorenza Cicale; G. De Rosa; A. Ferrari; R. Hofmann-Wellenhof; Josep Malvehy; Ketty Peris; Maria A. Pizzichetta; Susana Puig; Massimiliano Scalvenzi; Stefania Staibano; Vincenzo Ruocco

Background  Benign melanocytic skin lesions may be difficult to differentiate from melanoma both clinically and dermoscopically. One of the most confounding dermoscopic features, commonly seen in melanoma but in our experience also in melanocytic naevi, is represented by the so‐called blue–white structures (BWS).


Melanoma Research | 2002

Melanoma with benign melanocytic naevus components: reappraisal of clinicopathological features and prognosis.

Steven Kaddu; Josef Smolle; Paulus Zenahlik; R. Hofmann-Wellenhof; Helmut Kerl

The clinicopathological features and prognosis of primary cutaneous malignant melanoma with benign melanocytic naevus (BMN) components are still under debate. The purpose of this study was to characterize further the clinical and histopathological features of naevus-associated melanomas, with emphasis on the BMN components, and to examine their prognosis based on a large series. Following a histopathological review of 667 consecutive cases of primary cutaneous melanoma, 148 melanomas with BMN components (22.1%) were identified for further study. A control group of 519 melanomas without BMN components seen in a similar period were also studied. Clinically, patients with melanomas containing BMN components (n = 148; age range 25–86 years, mean age 54 ± 16 years; male to female ratio 1:1.02) presented with tumours located mainly on the trunk (34.5%), followed by the upper extremities (24.3%), lower extremities (20.3%), and head and neck (14.2%). Compared with tumours without BMN components (n = 519; age range 19–89 years, mean age 57 ± 15 years; male to female ratio 1:1.3), melanomas with BMN components occurred in slightly younger individuals (P = 0.027). Histopathologically, BMN components mainly showed features of acquired naevi (total 87 cases; dysplastic, 80 cases; banal, seven cases) or congenital naevi (total 57 cases; superficial, 56 cases; deep, one case), but a minority of these lesions (four cases) could not be further subcategorized. Generally, melanomas containing BMN components were relatively thinner than melanomas without BMN components (mean Breslow index 0.95 ± 0.83 mm and 1.3 ± 1.6 mm, respectively) (P = 0.015). The follow-up data available in 69 patients with naevus-associated melanomas consistently revealed a relatively good outcome (5 year metastasis-free survival rate 93.75%), although no statistical difference in prognosis was observed between this group and a subset of 283 melanomas patients without BMN components stratified by tumour thickness. We conclude that BMN components in naevus-associated melanomas constitute a heterogeneous group morphologically, consisting mainly of dysplastic and superficial congenital naevi. This finding indicates a more important role for superficial congenital naevus as a precursor lesion of naevus-associated melanomas than presently recognized. Patients with naevus-associated melanomas generally show a good clinical outcome, reflecting their small Breslow index.


British Journal of Dermatology | 2008

In vivo confocal laser scanning microscopy of melanocytic skin tumours: diagnostic applicability using unselected tumour images.

Armin Gerger; R. Hofmann-Wellenhof; Uwe Langsenlehner; Erika Richtig; Silvia Koller; Wolfgang Weger; Verena Ahlgrimm-Siess; Michael Horn; Hellmut Samonigg; Josef Smolle

Background  In vivo confocal laser scanning microscopy (CLSM) represents a novel imaging tool that allows the noninvasive examination of skin cancer morphology in real time at a ‘quasi‐histopathological’ resolution viewing microanatomical structures and individual cells.


British Journal of Dermatology | 2009

In vivo confocal laser scanning microscopy in the diagnosis of melanocytic skin tumours

Armin Gerger; R. Hofmann-Wellenhof; Hellmut Samonigg; Josef Smolle

Summary Melanoma of the skin represents one of the greatest challenges in early or preventive detection. Whereas surgical excision in early stages of melanoma development is almost always curative, delayed recognition puts the patient at risk for destructive growth and death from disease once the tumour has progressed to competence for metastasis. The worldwide introduction of dermoscopy has led to improved diagnostic accuracy for melanocytic skin tumours. Whereas dermoscopy has probably reached the method’s inherent potential diagnostic accuracy because of the lack of cellular level evaluation, further improvements could be expected by in vivo confocal laser scanning microscopy. In vivo confocal microscopy represents a novel imaging tool that allows the noninvasive examination of skin cancer morphology in real time at a ‘quasihistopathological’ resolution viewing microanatomical structures and individual cells. Numerous morphological confocal features of melanocytic skin tumours have been described and histopathological correlates of confocal structures have been previously elucidated. Recently, several studies have evaluated the diagnostic accuracy of in vivo confocal microscopy for melanocytic skin tumours, investigating approximately 50 000 tumour images. Remarkably, sensitivity superior to the diagnostic accuracy achieved with dermoscopy could be reached by this imaging modality. These studies represent a significant contribution to the body of research necessary for the evaluation and implementation of in vivo confocal microscopy in clinical practice to avoid many currently unnecessary biopsies. In vivo confocal microscopy probably augurs a sea change in the way we evaluate melanocytic skin tumours in the future and will ultimately move the art of histological diagnosis closer to the bedside.


British Journal of Dermatology | 2009

Reflectance confocal microscopy of facial lentigo maligna and lentigo maligna melanoma: a preliminary study.

Verena Ahlgrimm-Siess; Cesare Massone; Alon Scope; Regina Fink-Puches; Erika Richtig; Ingrid H. Wolf; Silvia Koller; Armin Gerger; Josef Smolle; R. Hofmann-Wellenhof

Background  Facial lentigo maligna (LM) and lentigo maligna melanoma (LMM) may be difficult to diagnose clinically and dermoscopically. Reflectance confocal microscopy (RCM) enables the in vivo assessment of equivocal skin lesions at a cellular level.


Pathology Research and Practice | 1989

Vascular Architecture of Melanocytic Skin Tumors: A Quantitative Immunohistochemical Study Using Automated Image Analysis

Josef Smolle; Hp Soyer; R. Hofmann-Wellenhof; Freyja-Maria Smolle-Juettner; Helmut Kerl

The present study examines the distribution of blood vessels in melanocytic skin tumors. Fresh frozen sections of 11 cases each of benign nevocellular nevus, primary malignant melanoma and metastatic malignant melanoma were stained with the endothelium-specific monoclonal antibody BMA 120 and evaluated by an automated image analysis system. Additionally, the proliferative activity was assessed in parallel sections using Ki 67 monoclonal antibody. There were only slight differences between the diagnostic groups as to the vascular distribution in the tumor center, but there were remarkable differences in the connective tissue at the base of the lesions: The area occupied by small vessels (minimum diameter less than 20 microns) was 0.3 +/- 0.05% in benign nevi, 0.6 +/- 0.05% in primary malignant melanoma, and 1.2 +/- 0.10% in metastatic malignant melanoma (U-test: p less than or equal to 0.05). The proliferative activity within each lesion showed a strong positive correlation with the number of small vessels at the base of the tumor (linear regression analysis: r = 0.86; p less than or equal to 0.0001). The findings demonstrate that neovascularization in malignant melanocytic tumors takes place predominantly in the surrounding host tissue and is closely related to the proliferative activity.


British Journal of Dermatology | 2004

Temozolomide and interferon α2b in metastatic melanoma stage IV

Erika Richtig; R. Hofmann-Wellenhof; H. Pehamberger; Ch. Forstinger; K. Wolff; P. Mischer; J. Raml; P. Fritsch; B. Zelger; G. Ratzinger; J. Koller; A. Lang; K. Konrad; E. Kindermann‐Glebowski; A. Seeber; A. Steiner; R. Fialla; W. Pachinger; C. Kos; G. Klein; H. Kehrer; Helmut Kerl; H. Ulmer; Josef Smolle

Background  A multicentre, centrally randomized, open‐labelled study with temozolomide and interferon (IFN)‐α2b was carried out to study the therapeutic effect in patients with metastatic melanoma stage IV.


Dermatology | 1994

Spitz’s Nevus Arising on a Nevus spilus

R. Hofmann-Wellenhof; Hp Soyer; Josef Smolle; Helmut Kerl

The first case of a solitary dermal Spitzs nevus arising on a nevus spilus is described. The special variant of a combined Spitzs nevus may cause difficulties in differential diagnosis from malignant melanoma in association with a nevus spilus.


Journal of Cutaneous Pathology | 1995

Confocal laser scanning microscopy: a new optical microscopic technique for applications in pathology and dermatology

Regina Fink-Puches; R. Hofmann-Wellenhof; Josef Smolle; Helmut Kerl

Confocal laser scanning microscopy (CLSM) is a new optical microscopic technique, which offers significant advantages over conventional microscopy. CLSM is microscopy of optical sections. Light, which is emitted from regions other than the focal plane, is cut off by introducing a diaphragm in the beam path. The result is an optical “slice”, which shows more details because the blurring from out of focus haze disappears. It has been repeatedly used in experimental, but also in diagnostic dermatopathology. The “in vivo” confocal microscopy, applied directly to the intact skin provides details of living cells in the superficial layers comparable to that of fixed and stained tissue. While the extent of its future applications is hard to predict, its potential for applications in dermatology appears enormous, particularly for studies of fixed or living tissues, where it is desirable to obtain clear images many micrometers below the surface of the tissue under examination.


Journal of The European Academy of Dermatology and Venereology | 2015

High-definition optical coherence tomography algorithm for discrimination of basal cell carcinoma from clinical BCC imitators and differentiation between common subtypes

Marc Boone; Mariano Suppa; Giovanni Pellacani; A. Marneffe; M. Miyamoto; I. Alarcon; C. Ruini; R. Hofmann-Wellenhof; Josep Malvehy; Gregor B. E. Jemec; V. del Marmol

Preliminary studies have described morphological features of basal cell carcinoma (BCC) imaged by high‐definition optical coherence tomography (HD‐OCT) and suggested that this technique may aid in its diagnosis and management. However, systematic studies evaluating the accuracy of HD‐OCT for the diagnosis of BCC are lacking.

Collaboration


Dive into the R. Hofmann-Wellenhof's collaboration.

Top Co-Authors

Avatar

Josef Smolle

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ingrid H. Wolf

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Erika Richtig

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar

Ketty Peris

Catholic University of the Sacred Heart

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge